Prospective study of endogenous tissue plasminogen activator and risk of stroke.
about
The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.Testing for endothelial dysfunction.Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillationEtiology and pathophysiology of stroke as a complex trait.Fluvastatin: effects beyond cholesterol lowering.Alcohol consumption and risk of deep venous thrombosis and pulmonary embolism in older persons.Endothelial dysfunction in the pathogenesis of atherosclerosis.The -7351C/T polymorphism in the TPA gene and ischemic stroke risk: a meta-analysisThe relationship between infection, inflammation, and cardiovascular disease: an overview.Obesity, haemostasis and the fibrinolytic system.Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic strokeRelation of C-reactive protein to endothelial fibrinolytic function in healthy adults.Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function.The metabolic syndrome: an emerging risk state for cardiovascular disease.Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice.Tissue Factor Pathway Inhibitor, Activated Protein C Resistance, and Risk of Coronary Heart Disease Due To Combined Estrogen Plus Progestin TherapySelf-reported habitual short sleep duration is associated with endothelial fibrinolytic dysfunction in men: a preliminary report.Haplotype Based Association Study between t-PA Gene and Essential HypertensionPeculiarities of stroke risk in women.Cerebral small vessel disease: genetic risk assessment for prevention and treatment.Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseasesAngiotensin converting enzyme inhibitors--do they have an anti-ischemic action?A reliable marker of endothelial cell dysfunction: does it exist?The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis.Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness.Association of the fibrinolytic system and hemorheology with symptoms in patients with carotid occlusive disease.Human gender differences in fibrinolytic responses to exercise training and their determinants.Effect of alcohol intoxication on the risk of venous thromboembolism: A nationwide retrospective cohort study.Classic risk factors, hypercoagulability and migraine in young women with cerebral lacunar infarctions.Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke.Associations between insulin resistance and thrombotic risk factors in high-risk South Asian subjects.Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular diseaseThe relationship between plasma androgens (dehydroepiandrosterone sulfate and testosterone), insulin, coagulation and fibrinolytic factors in men with coronary arteriosclerosis
P2860
Q31899830-8F640F10-859E-49F1-9E6B-FB88168CD550Q33709508-9594BF94-6ACB-4851-A074-87F5CDF0D4ABQ34008359-A8362838-515B-4CEF-9645-2F85699B9619Q34025555-88597827-31E0-4741-A55E-915C332CA012Q34065857-9722D727-3332-46BC-BC04-0215C5A8DDC4Q34126048-F8AA49EE-574E-4338-BDE5-EBA2EDE864B5Q34395534-25FBFB49-2E35-4285-98BF-7F4F4F3D882EQ34430443-1744102E-88C2-4025-B689-14096D221B7BQ34551522-87E36A3C-D70F-41CB-93DC-5DFF4E78D6CDQ34557639-C54CD340-530A-4ADD-A43B-8FF60749CF70Q34743382-29FF8776-325D-4948-8FE9-4BB497229DA9Q35608208-9744606D-F4E6-4034-8C87-8011E87ACDECQ35774550-11567E71-DCDE-46D3-8316-615BA0CAECAEQ35816401-D71A1FFB-378F-4CC1-B47C-D545195051C3Q35824621-02318DE2-A46A-4BB1-9157-32027EFCDAC4Q36030428-A36CA82A-3E8A-4429-82A1-422E10AACAC7Q36520556-466DCEC4-754C-4BF7-BFF3-A9AA76A0C493Q36526467-CBCB5C6E-0E09-4470-9FFD-EE8073BED12AQ36735179-DD6ADC19-30ED-46B0-88B9-1FCA7B05A44CQ36986385-E9099921-3155-451B-A60B-30147A03F506Q37176377-C47F1D5D-EA51-440B-A38C-F73073867EBFQ37219105-D67F650F-8C39-4A8B-8EC7-6F4D7501486EQ38297868-2227F909-68D3-4EAF-A758-07A89BBA76A8Q40401880-977E12EB-2093-4734-BC00-DB1FBC0AE057Q44010976-625A5F04-C7C7-4F15-A3C7-93DECB6E4323Q44514165-4458996D-8F4D-4638-BF81-541E68C967D7Q46641204-4E359F87-5679-4CDA-9517-950A4F45E6DFQ46665860-2259AA97-8FD8-46A7-BDCA-48AB7818B3B1Q47121555-1E6EC2AA-C1CC-4CFE-93CF-8662B7F78B24Q48666113-B82DAFE3-8EE5-43BC-9BAC-5502C8231127Q49039359-D8C9C170-5A3C-4522-91E3-366ECB728553Q52860018-56DAFBB7-B356-4D57-9C73-4987211B5413Q54888331-0BAD6E98-AFCF-4495-90C5-1F1301D6F40BQ58282320-985DA54D-47EF-40BF-A98A-FC86E52ED563
P2860
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
@en
type
label
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
@en
prefLabel
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
@en
P2093
P1433
P1476
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
@en
P2093
C H Hennekens
D E Vaughan
J E Manson
M J Stampfer
P M Ridker
P304
P356
10.1016/S0140-6736(94)90064-7
P407
P577
1994-04-01T00:00:00Z